Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Jasper Therapeutics, Inc. (JSPR)

Context Therapeutics Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. Context Therapeutics Inc. is the larger, with a market value of $17.3M against $15.6M — 1.1× the size. Across the 8 metrics below, Context Therapeutics Inc. leads on 4 and Jasper Therapeutics, Inc. on 4.

Valuation

Metric CNTX JSPR Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.47 339.77 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.51 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (252.63%) (9.50%) (32.88%)
Free cash flow yield (188.15%) (12.55%) (23.13%)

Profitability

Metric CNTX JSPR Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) (255.05%) (51.96%)
Return on assets (68.96%) (109.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTX JSPR Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 17.39% 19.22% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX JSPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 1.48 4.97
Net debt to EBITDA 1.66 0.35 1.01

Dividend

Metric CNTX JSPR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTX JSPR Biotechnology median
Market cap 17.27m 15.62m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack